Tailored rehab program aims to help young adults reclaim life after cancer

NCT ID NCT07692763

First seen Jul 09, 2026 · Last updated Jul 10, 2026 · Updated 1 time

Summary

This trial tests a 16-week rehabilitation program called YATAC, designed specifically for young adults aged 18–39 who have or have had cancer. The program includes physical activity, mental health support, nutrition advice, and help with education or work. Researchers want to see if running a larger study is possible and whether the program improves quality of life and daily functioning.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
YATAC programme (behavioural intervention including physical activity, mental health support, nutrition, and education/work guidance)
What this could lead to
If successful, this program could become a standard, age-specific rehabilitation option that helps young adults with cancer regain quality of life and return to everyday activities.
What could go wrong
This is a small pilot study focused on feasibility, not effectiveness. The program may not show clear benefits, and results may not apply to all young adults with cancer.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Folkesundhed (Public Health), the Municipality of Aarhus

    RECRUITING

    Aarhus, 8000, Denmark

    Contact Phone: •••-•••-•••• Email: •••••@•••••

More trials for these conditions

Other studies related to the condition(s) this trial covers.